Clinical Trials Browser

Completed × onartuzumab × Tumor-Agnostic × Clear all

NCT02031731 2017-03-14

The Pharmacokinetics and Safety of Onartuzumab (MetMAb) in Chinese Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Neoplasms